Chris Littlewood, Chief Executive of Activotec, commented “2008 peptide synthesizer sales have exceeded even our most optimistic expectations”. “Driven by the imminent introduction of the new Activo-P14 Peptide Synthesizer, the Activo-S44 Oligosaccharide Synthesizer as well as reactor heating, UV monitoring and large scale (>5mole) synthesis capabilities for the Activo-P11 we expect to grow even more in 2009”. He added “We are the only European company with international service and support teams that are exclusively focused on peptide synthesis instrumentation and services. This enables Activotec to be uniquely positioned to provide customers with informed technical assistance enabling them to get the most from their peptide synthesizer”.
For further information on the latest products and services for high quality peptide synthesis and synthesis automation please contact Activotec on email email@example.com or telephone +44 1223 260008.